Avalo Therapeutics, Inc. Annual General and Administrative Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Avalo Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2013 to 2024.
  • Avalo Therapeutics, Inc. General and Administrative Expense for the quarter ending December 31, 2024 was $5.23M, a 95.7% increase year-over-year.
  • Avalo Therapeutics, Inc. General and Administrative Expense for the twelve months ending December 31, 2024 was $17.2M, a 67.4% increase year-over-year.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2024 was $17.2M, a 67.4% increase from 2023.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2023 was $10.3M, a 50.3% decline from 2022.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2022 was $20.7M, a 16% decline from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $17.2M +$6.94M +67.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $10.3M -$10.4M -50.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $20.7M -$3.95M -16% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-29
2021 $24.7M +$7.24M +41.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $17.4M +$7.29M +72.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $10.1M -$388K -3.69% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $10.5M +$2.57M +32.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $7.94M +$858K +12.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $7.08M +$2.66M +60.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $4.42M -$452K -9.28% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $4.88M +$855K +21.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $4.02M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.